Resolution of therapy-resistant pyoderma gangrenosum with upadacitinib

JAAD Case Rep. 2023 May 22:37:89-91. doi: 10.1016/j.jdcr.2023.05.016. eCollection 2023 Jul.

Authors

Lisa Van Eycken¹, Anne-Catherine Dens^{1

2}, Kurt de Vlam^{2

3}, Barbara Neerinckx^{2

3}, Petra De Haes^{1

4}

Affiliations

¹ Department of Dermatology, UZ Leuven, Leuven, Belgium.
² Skeletal Biology and Engineering Research Centre, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
³ Department of Rheumatology, University hospitals Leuven, Leuven, Belgium.
⁴ Department of Microbiology, Immunology en Transplantation, KU Leuven, Leuven, Belgium.

No abstract available

Keywords: janus kinase inhibitor; pyoderma gangrenosum; upadacitinib.

Publication types

Case Reports